Centene Corp (CNC) shareholders
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/302% above fair value
$71.27+1.00 (+1.42%)
Close on Nov 13, 2026Market cap $35.28BP/E 24.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
98.6%
488M of 495M shares
Institutional holders
1,003
223 new, 74 sold out
Net institutional buying
17M
In Q2 2026
Insider trades, 12 months
0 buys · 5 sales
Net sold $14.63M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 38,215,413 | 7.70% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Capital Management | 35,946,964 | 7.30% | 13G (passive) | Mar 31, 2026 |
| AQR Capital Management Holdings, LLC Joint filing with AQR Capital Management, LLC (6.47%) | 31,798,738 | 6.47% | 13G (passive) | Dec 31, 2025 |
| FMR LLC Joint filing with Abigail P. Johnson (5.40%) | 26,577,525 | 5.40% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 41,446,046 | 8.37% | $2.66B | +1,623,647 | 0.04% |
| Vanguard Capital Management LLC | 31,478,140 | 6.36% | $2.02B | +244,075 | 0.04% |
| Aqr Capital Management LLC | 28,678,701 | 5.79% | $1.84B | −4,935,086 | 0.64% |
| Vanguard Portfolio Management LLC | 22,352,704 | 4.52% | $1.43B | +723,167 | 0.06% |
| State Street Corp | 21,965,370 | 4.44% | $1.41B | +319,242 | 0.04% |
| Geode Capital Management, LLC | 13,309,729 | 2.69% | $854.00M | +322,217 | 0.05% |
| Wellington Management Group Llp | 13,301,215 | 2.69% | $853.80M | +10,757,914 | 0.15% |
| Ameriprise Financial Inc | 12,419,397 | 2.51% | $798.16M | +2,291,199 | 0.16% |
| Invesco Ltd. | 11,179,844 | 2.26% | $717.63M | +563,673 | 0.06% |
| Harris Associates L P | 11,124,640 | 2.25% | $714.09M | −2,969,891 | 0.95% |
| Morgan Stanley | 10,051,700 | 2.03% | $645.22M | +171,464 | 0.03% |
| Price T Rowe Associates Inc /Md/ | 8,701,030 | 1.76% | $558.52M | +1,736,150 | 0.06% |
| Norges Bank | 7,651,758 | 1.55% | $491.17M | New | 0.05% |
| Arrowstreet Capital, Limited Partnership | 7,452,257 | 1.51% | $478.36M | +682,492 | 0.21% |
| Assenagon Asset Management S.A. | 7,432,058 | 1.50% | $477.06M | +3,606,783 | 0.30% |
| Charles Schwab Investment Management Inc | 6,975,962 | 1.41% | $447.79M | +78,350 | 0.06% |
| Acadian Asset Management LLC | 6,851,314 | 1.38% | $439.74M | +2,039,763 | 0.52% |
| Goldman Sachs Group Inc | 6,359,176 | 1.28% | $408.20M | +785,632 | 0.04% |
| Two Sigma Investments, LP | 6,348,038 | 1.28% | $407.48M | −395,908 | 0.30% |
| Victory Capital Management Inc | 5,884,626 | 1.19% | $377.73M | +2,912,366 | 0.21% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,003 | 488M | 98.6% | 223 / 346 | 339 / 74 | 69M | 52M |
| Q1 2026 | 867 | 474M | 95.8% | 103 / 307 | 351 / 138 | 115M | 56M |
| Q4 2025 | 913 | 478M | 96.6% | 189 / 340 | 288 / 104 | 70M | 53M |
| Q3 2025 | 849 | 462M | 93.2% | 169 / 334 | 265 / 179 | 112M | 131M |
| Q2 2025 | 871 | 481M | 97.2% | 111 / 353 | 300 / 124 | 34M | 37M |
| Q1 2025 | 898 | 485M | 98.0% | 124 / 325 | 330 / 88 | 49M | 41M |
| Q4 2024 | 876 | 482M | 97.3% | 137 / 283 | 355 / 126 | 56M | 73M |
| Q3 2024 | 883 | 500M | 100.0% | 89 / 305 | 358 / 94 | 68M | 48M |
| Q2 2024 | 897 | 528M | 100.0% | 87 / 330 | 358 / 108 | 37M | 48M |
| Q1 2024 | 930 | 540M | 100.0% | 116 / 382 | 297 / 68 | 39M | 30M |
| Q4 2023 | 895 | 532M | 100.0% | 141 / 309 | 324 / 58 | 52M | 28M |
| Q3 2023 | 824 | 508M | 100.0% | 74 / 322 | 303 / 75 | 27M | 39M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
762 funds held CNC in Q2 2026, 55% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CNC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 15,674,974 | 3.17% | $1.01B | 0.04% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 12,157,702 | 2.46% | $780.40M | 0.05% | Jun 30, 2026 |
| Oakmark Select Fund | 7,525,000 | 1.52% | $483.03M | 5.81% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 6,450,265 | 1.30% | $414.04M | 0.05% | Jun 30, 2026 |
| Vanguard Health Care Fund | 6,149,030 | 1.24% | $382.59M | 1.00% | Jul 31, 2026 |
| Fidelity 500 Index Fund | 5,978,373 | 1.21% | $356.31M | 0.04% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 5,661,113 | 1.14% | $363.39M | 0.19% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 5,349,639 | 1.08% | $343.39M | 0.15% | Jun 30, 2026 |
| Vanguard Wellington Fund | 4,396,372 | 0.89% | $262.02M | 0.21% | May 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 3,586,880 | 0.72% | $230.24M | 0.34% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 3,314,038 | 0.67% | $212.73M | 0.52% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,851,554 | 0.58% | $177.42M | 0.18% | Jul 31, 2026 |
| VictoryShares Free Cash Flow ETF | 2,611,143 | 0.53% | $167.61M | 2.16% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 2,545,229 | 0.51% | $163.38M | 0.05% | Jun 30, 2026 |
| Invesco S&P 500 Revenue ETF | 2,417,955 | 0.49% | $144.11M | 1.59% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sarah London | Chief Executive Officer, Director | 1,188,831 | 0.24% | Mar 17, 2026 |
| Michael A. Carson | Group President, Medicare&Spec | 116,577 | 0.02% | Oct 15, 2026 |
| Theodore J. Pienkos | Corporate Controller & CAO | 28,751 | 0.01% | Sep 16, 2026 |
| Christopher Koster | Secretary & General Counsel | 248,954 | 0.05% | Aug 27, 2026 |
| Susan Raye Smith | Chief Operating Officer | 212,237 | 0.04% | Jun 15, 2026 |
| Daniel P. Finke | Group President, Markets&Comm | 228,127 | 0.05% | May 18, 2026 |
| Tanya M. McNally | Chief People Officer | 127,258 | 0.03% | Apr 16, 2026 |
| Andrew Lynn Asher | Chief Financial Officer | 747,989 | 0.15% | Mar 17, 2026 |
| Katie Casso | Corporate Controller & CAO | 109,776 | 0.02% | Mar 17, 2026 |
| Lauren M. Tyler | Director | 3,698 | 0.00% | Sep 30, 2026 |
| Christopher J. Coughlin | Director | 49,348 | 0.01% | Sep 30, 2026 |
| Kenneth Tanji | Director | 13,093 | 0.00% | Sep 30, 2026 |
| Frederick H. Eppinger | Director | 370,402 | 0.07% | Sep 30, 2026 |
| Theodore R. Samuels II | Director | 57,796 | 0.01% | Sep 30, 2026 |
| Paul J. Diaz | Director | 0 | – | Jul 28, 2026 |
| Kenneth A. Burdick | Director | 283,584 | 0.06% | Jun 11, 2026 |
| Jessica L. Blume | Director | 32,607 | 0.01% | May 13, 2026 |
| H. James Dallas | Director | 49,567 | 0.01% | May 13, 2026 |
| Monte E. Ford | Director | 14,827 | 0.00% | May 13, 2026 |
| Wayne S. DeVeydt | Director | 19,523 | 0.00% | Jul 2, 2025 |
| Thomas Greco | Director | 22,888 | 0.00% | May 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael A. Carson Group President, Medicare&Spec | Oct 15, 2026 | Tax withholding | −7,130 | $70.16 | $500.24K | 115,752 |
| Theodore R. Samuels II Director | Sep 30, 2026 | Award | +583 | – | – | 25,796 |
| Frederick H. Eppinger Director | Sep 30, 2026 | Award | +864 | – | – | 370,402 |
| Kenneth Tanji Director | Sep 30, 2026 | Award | +603 | – | – | 13,093 |
| Christopher J. Coughlin Director | Sep 30, 2026 | Award | +583 | – | – | 19,294 |
| Lauren M. Tyler Director | Sep 30, 2026 | Award | +482 | – | – | 3,698 |
| Theodore J. Pienkos Corporate Controller & CAO | Sep 15, 2026 | Tax withholding | −1,092 | $69.41 | $75.80K | 28,751 |
| Christopher Koster Secretary & General Counsel | Aug 26, 2026 | Sale | −56,500 | $66.90 | $3.78M | 248,854 |
| Christopher Koster Secretary & General Counsel | Aug 18, 2026 | Sale | −47,603 | $65.36 | $3.11M | 305,354 |
| Paul J. Diaz Director | Jul 28, 2026 | Award | +2,771 | – | – | 2,771 |
| Lauren M. Tyler Director | Jul 17, 2026 | Award | +3,155 | – | – | 3,216 |
| Kenneth Tanji Director | Jun 30, 2026 | Award | +581 | – | – | 12,490 |
| Lauren M. Tyler Director | Jun 30, 2026 | Award | +61 | – | – | 61 |
| Theodore R. Samuels II Director | Jun 30, 2026 | Award | +465 | – | – | 25,213 |
| Frederick H. Eppinger Director | Jun 30, 2026 | Award | +833 | – | – | 369,538 |
| Christopher J. Coughlin Director | Jun 30, 2026 | Award | +562 | – | – | 18,711 |
| Susan Raye Smith Chief Operating Officer | Jun 15, 2026 | Tax withholding | −483 | $65.19 | $31.49K | 212,237 |
| Kenneth A. Burdick Director | Jun 10, 2026 | Sale | −80,000 | $64.55 | $5.16M | 197,086 |
| Jessica L. Blume Director | May 12, 2026 | Award | +3,992 | – | – | 32,357 |
| Christopher J. Coughlin Director | May 12, 2026 | Award | +3,992 | – | – | 18,149 |
| Theodore R. Samuels II Director | May 12, 2026 | Award | +3,992 | – | – | 24,748 |
| Monte E. Ford Director | May 12, 2026 | Award | +3,992 | – | – | 14,827 |
| Frederick H. Eppinger Director | May 12, 2026 | Award | +6,654 | – | – | 368,705 |
| H. James Dallas Director | May 12, 2026 | Award | +3,992 | – | – | 47,874 |
| Kenneth A. Burdick Director | May 12, 2026 | Award | +3,992 | – | – | 277,086 |
| Kenneth Tanji Director | May 12, 2026 | Award | +3,992 | – | – | 11,909 |
| Tanya M. McNally Chief People Officer | Apr 15, 2026 | Tax withholding | −964 | $37.26 | $35.92K | 127,258 |
| Christopher J. Coughlin Director | Mar 31, 2026 | Award | +1,140 | – | – | 14,157 |
| Kenneth Tanji Director | Mar 31, 2026 | Award | +1,179 | – | – | 7,917 |
| Frederick H. Eppinger Director | Mar 31, 2026 | Award | +1,690 | – | – | 362,051 |
| Theodore R. Samuels II Director | Mar 31, 2026 | Award | +943 | – | – | 20,756 |
| Katie Casso Corporate Controller & CAO | Mar 15, 2026 | Tax withholding | −3,359 | $34.45 | $115.72K | 109,776 |
| Christopher Koster Secretary & General Counsel | Mar 15, 2026 | Tax withholding | −9,087 | $34.45 | $313.05K | 352,836 |
| Tanya M. McNally Chief People Officer | Mar 15, 2026 | Tax withholding | −2,785 | $34.45 | $95.94K | 128,222 |
| Sarah London Chief Executive Officer, Director | Mar 15, 2026 | Tax withholding | −36,061 | $34.45 | $1.24M | 1,188,831 |
| Andrew Lynn Asher Chief Financial Officer | Mar 15, 2026 | Tax withholding | −15,241 | $34.45 | $525.05K | 747,989 |
| Susan Raye Smith Chief Operating Officer | Mar 15, 2026 | Tax withholding | −2,918 | $34.45 | $100.53K | 212,720 |
| Katie Casso Corporate Controller & CAO | Jan 26, 2026 | Award | +26,036 | – | – | 113,135 |
| Susan Raye Smith Chief Operating Officer | Jan 26, 2026 | Award | +112,823 | – | – | 215,638 |
| Tanya M. McNally Chief People Officer | Jan 26, 2026 | Award | +74,311 | – | – | 131,007 |
| Andrew Lynn Asher Chief Financial Officer | Jan 26, 2026 | Award | +173,573 | – | – | 763,230 |
| Christopher Koster Secretary & General Counsel | Jan 26, 2026 | Award | +126,925 | – | – | 361,923 |
| Sarah London Chief Executive Officer, Director | Jan 26, 2026 | Award | +520,720 | – | – | 1,224,892 |
| Christopher Koster Secretary & General Counsel | Jan 26, 2026 | Award | +126,925 | – | – | 388,862 |
| Tanya M. McNally Chief People Officer | Jan 26, 2026 | Award | +74,311 | – | – | 133,080 |
| Andrew Lynn Asher Chief Financial Officer | Jan 26, 2026 | Award | +173,573 | – | – | 831,215 |
| Sarah London Chief Executive Officer, Director | Jan 26, 2026 | Award | +520,720 | – | – | 1,365,995 |
| Susan Raye Smith Chief Operating Officer | Jan 26, 2026 | Award | +112,823 | – | – | 225,289 |
| Katie Casso Corporate Controller & CAO | Jan 26, 2026 | Award | +26,036 | – | – | 122,371 |
| Tanya M. McNally Chief People Officer | Jan 15, 2026 | Tax withholding | −725 | $46.17 | $33.47K | 58,769 |
| Christopher J. Coughlin Director | Dec 31, 2025 | Award | +729 | – | – | 13,017 |
| Kenneth A. Burdick Director | Dec 31, 2025 | Award | +729 | – | – | 273,094 |
| Kenneth Tanji Director | Dec 31, 2025 | Award | +790 | – | – | 6,738 |
| Theodore R. Samuels II Director | Dec 31, 2025 | Award | +608 | – | – | 19,813 |
| Frederick H. Eppinger Director | Dec 31, 2025 | Award | +608 | – | – | 360,361 |
| Kenneth A. Burdick Director | Dec 4, 2025 | Sale | −32,796 | $39.00 | $1.28M | 272,365 |
| Kenneth A. Burdick Director | Dec 3, 2025 | Sale | −33,211 | $39.04 | $1.30M | 305,161 |
| Kenneth A. Burdick Director | Sep 30, 2025 | Award | +852 | – | – | 338,372 |
| Kenneth Tanji Director | Sep 30, 2025 | Award | +803 | – | – | 5,948 |
| Frederick H. Eppinger Director | Sep 30, 2025 | Award | +710 | – | – | 359,753 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
2.14%
11M shares short
Days to cover
2.0
At 5M shares a day
Change since last report
-3.9%
From 11M shares
Short volume, 20 days
47.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Centene's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,591 shares on Aug 26, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Christopher Koster Officer | Aug 26, 2026 | 56,500 | $3.78M | Aug 26, 2026 | ESPP Purchase |
| Kenneth A. Burdick Former Director | Aug 26, 2026 | 43,600 | $2.83M | Aug 26, 2026 | Restricted Stock Vesting |
| Christopher Koster Officer | Aug 18, 2026 | 47,603 | $3.11M | Aug 18, 2026 | Restricted Stock Vesting |
| Kenneth A. Burdick Former Director | Aug 5, 2026 | 100,000 | $6.82M | Aug 5, 2026 | Restricted Stock Vesting |
| Kenneth A. Burdick Director | Jun 10, 2026 | 80,000 | $5.16M | Jun 10, 2026 | Restricted Stock Vesting |
| Kenneth A. Burdick Director | Dec 4, 2025 | 32,796 | $1.28M | Dec 4, 2025 | Restricted Stock Vesting |
| Kenneth A. Burdick Director | Dec 3, 2025 | 33,211 | $1.30M | Dec 3, 2025 | Restricted Stock Vesting |
| Wayne S. DeVeydt Director | Oct 15, 2025 | 5,489 | $196.74K | Oct 15, 2025 | Stock Bonus |
| Wayne S. DeVeydt Director | Sep 9, 2025 | 10,775 | $314.55K | Sep 9, 2025 | Stock Bonus |
| Kenneth J. Fasola Officer | Mar 21, 2025 | 8,500 | $501.97K | Mar 21, 2025 | Restricted Stock Vesting |
| Christopher J. Coughlin Director | May 24, 2024 | 878 | $67.38K | May 14, 2024 | Open Market Purchase |
| Kenneth J. Fasola Officer | May 13, 2024 | 8,000 | $621.00K | May 13, 2024 | Restricted Stock Vesting |
| David P. Thomas Officer | Mar 7, 2024 | 5,000 | $387.48K | Mar 5, 2024 | Restricted Stock Vesting |
| David P. Thomas Officer | Mar 5, 2024 | 5,000 | $387.48K | Mar 5, 2024 | Restricted Stock Vesting |
| Lori Jean Robinson Director | Feb 13, 2024 | 10,000 | $774.15K | Feb 13, 2024 | Option Granted - 11/15/2019 |
See a number that looks wrong?